WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic.

作者信息

Mallapaty Smriti

出版信息

Nature. 2021 Jun;594(7862):161-162. doi: 10.1038/d41586-021-01497-8.

DOI:10.1038/d41586-021-01497-8

PMID:34089030

Abstract

摘要

相似文献

[1]

WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic.

Nature. 2021-6

[2]

China's COVID vaccines are going global - but questions remain.

Nature. 2021-5

[3]

Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine.

Protein Cell. 2021-10

[4]

China's COVID vaccines have been crucial - now immunity is waning.

Nature. 2021-10

[5]

Will Omicron end the pandemic? Here's what experts say.

Nature. 2022-2

[6]

SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen.

J Med Virol. 2022-1

[7]

Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.

Front Immunol. 2021

[8]

Why COVID vaccines are so difficult to compare.

Nature. 2021-3

[9]

Six months of COVID vaccines: what 1.7 billion doses have taught scientists.

Nature. 2021-6

[10]

The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials.

Lancet Infect Dis. 2021-4

引用本文的文献

[1]

Prenatal maternal inactivated COVID-19 vaccination: the maternal and neonatal outcomes, a retrospective cohort study.

Front Pharmacol. 2024-2-28

[2]

Heat waves accelerate the spread of infectious diseases.

Environ Res. 2023-8-15

[3]

Impaired antibody response to inactivated COVID-19 vaccines in hospitalized patients with type 2 diabetes.

Hum Vaccin Immunother. 2023-12-31

[4]

One-Year Post-Vaccination Longitudinal Follow-Up of Quantitative SARS-CoV-2 Anti-Spike Total Antibodies in Health Care Professionals and Evaluation of Correlation with Surrogate Neutralization Test.

Vaccines (Basel). 2023-2-3

[5]

Reduced antibody response to COVID-19 vaccine composed of inactivated SARS-CoV-2 in diabetic individuals.

Front Public Health. 2022

[6]

Antibodies Induced by Homologous or Heterologous Inactivated (CoronaVac/BBIBP-CorV) and Recombinant Protein Subunit Vaccines (ZF2001) Dramatically Enhanced Inhibitory Abilities against B.1.351, B.1.617.2, and B.1.1.529 Variants.

Vaccines (Basel). 2022-12-9

[7]

Risk factors affecting COVID-19 vaccine effectiveness identified from 290 cross-country observational studies until February 2022: a meta-analysis and meta-regression.

BMC Med. 2022-11-25

[8]

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.

mBio. 2022-12-20

[9]

The early evolution of COVID-19 incidence and mortality among people aged under 80 years or 80 years and above after COVID-19 vaccine implementation in the state of Bahia, Brazil.

Vaccine. 2022-11-28

[10]

Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human.

Front Immunol. 2022

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献